pembrolizumab,cisplatin,gemcitabine,pemetrexed,Nivolumab,Ipilimumab
merck,BMS
['sclc', 'nsclc', 'keynote,671', 'lung', 'keynote 671']
as we get ready to hear the data from keynote 671 at #asco23 tomorrow, check out this episode of the podcast #lungcancerconsidered on resectable stage iii nsclc with drs. tina cascone, , and . 
Director of Thoracic Oncology & Developmental Therapeutics @LombardiCancer, Associate Professor @Georgetown, Co-Host Official @IASLC Podcast, #ITYSL, #HereWeGo